Dr. Dhananjoy Saha, Kushal Nandi, Amrita Chakraborty, and Dr. Dhrubo Jyoti Sen. “Zolgensma: World’s Most Expensive Drug of Choice; Survival of Motor Function for the Treatment of Spinal Muscular Atrophy Type 1: https://doi.Org/10.54037/WJPS.2021.91104”. World Journal of Pharmaceutical Sciences 9, no. 11 (November 1, 2021): 83–86. Accessed October 3, 2022. https://wjpsonline.com/index.php/wjps/article/view/zolgensma-motor-function-spinal-muscular-atrophy.